Entrada Therapeutics (TRDA) Earnings Report Date & History

Check the next TRDA earnings date, EPS forecasts, and historical earnings-related price changes

TRDA Earnings Report

Entrada Therapeutics reported earnings of -$ 0.94 per TRDA share on Nov 5, 2026, falling short of analysts' expectations by -6.93%.Meanwhile, the company posted an EPS of -$ 0.87 during the same period last year, marking a -11.75% change.

Report Date Nov 5, 2026
Forecasted EPS -$ 1.01
Earnings Per Share (Surprise) -$ 0.94   (+$ 0.07)
Last Year's EPS -$ 0.87
EPS YoY Change -11.75%

Entrada Therapeutics Earnings History

Out of the last 27 earnings reporting periods, Entrada Therapeutics beat analysts’ expectations 12 times and fell short of expectations 9 time(s). Entrada Therapeutics reported earnings per share of -$ 0.94 in the last report surpassing an estimated EPS of -$ 1.01 by -6.93%.

Report Date Forecasted EPS Reported EPS Last Year's EPS EPS YoY Change
Nov 5, 2026 -$ 1.01 -$ 0.94 -$ 1.06 11.32%
Aug 5, 2026 -$ 0.97 -$ 1.01 -$ 1.04 2.88%
May 7, 2026 -$ 1.06 -$ 0.95 -$ 0.42 -126.19%
Feb 26, 2026 -$ 1.32 -$ 0.94 $ 0.03 -3,233.33%
Nov 6, 2025 -$ 1.04 -$ 1.06 -$ 0.35 -202.86%
Aug 6, 2025 -$ 0.86 -$ 1.04 $ 1.55 -167.10%
May 8, 2025 -$ 0.78 -$ 0.42 $ 0.68 -161.76%
Feb 27, 2025 -$ 0.66 $ 0.03 -$ 0.29 110.34%
Nov 5, 2024 -$ 0.67 -$ 0.35 $ 1.02 -134.31%
Aug 13, 2024 $ 0.14 $ 1.55 -$ 0.78 298.72%
May 7, 2024 -$ 0.59 $ 0.68 -$ 0.21 423.81%
Mar 13, 2024 -$ 0.07 -$ 0.29 -$ 0.79 63.29%
Nov 7, 2023 -$ 0.74 $ 1.02 -$ 0.80 227.50%
Aug 8, 2023 -$ 0.43 -$ 0.78 -$ 0.74 -5.41%
May 10, 2023 -$ 0.77 -$ 0.21 -$ 0.69 69.57%
Mar 6, 2023 -$ 0.84 -$ 0.79 -$ 0.89 11.24%
Nov 7, 2022 -$ 0.76 -$ 0.80 -$ 9.78 91.82%
Aug 11, 2022 -$ 0.72 -$ 0.74 -$ 0.48 -53.04%
May 12, 2022 -$ 0.65 -$ 0.69 -$ 0.41 -68.60%
Mar 15, 2022 -$ 1.28 -$ 0.89 -$ 0.42 -110.12%

TRDA Earnings-Related Price Changes

Entrada Therapeutics’s stock was trading at $ 5.06 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, TRDA’s price decreased to $ 4.89 on Nov 6, 2026, recording a -3.36% price change in the 48-hour period.

Report Date EPS Price 1 Day Before Price 1 Day After Change
Nov 5, 2026 -$ 0.94 (-6.93%)$ 5.06$ 4.89-3.36%
Aug 5, 2026 -$ 1.01 (3.72%)$ 7.24$ 6.87-5.11%
May 7, 2026 -$ 0.95 (-10.38%)$ 16.03$ 6.84-57.33%
Feb 26, 2026 -$ 0.94 (-28.79%)$ 11.98$ 11.93-0.42%
Nov 6, 2025 -$ 1.06 (1.92%)$ 6.94$ 6.91-0.43%
Aug 6, 2025 -$ 1.04 (20.93%)$ 5.83$ 5.30-9.09%
May 8, 2025 -$ 0.42 (-46.15%)$ 8.16$ 8.382.70%
Feb 27, 2025 $ 0.03 (-104.55%)$ 12.02$ 11.94-0.67%
Nov 5, 2024 -$ 0.35 (-47.76%)$ 17.77$ 18.665.01%
Aug 13, 2024 $ 1.55 (1,007.14%)$ 14.21$ 15.8211.33%
May 7, 2024 $ 0.68 (-215.25%)$ 13.50$ 14.054.07%
Mar 13, 2024 -$ 0.29 (314.29%)$ 11.58$ 12.205.35%
Nov 7, 2023 $ 1.02 (-237.84%)$ 15.64$ 16.877.86%
Aug 8, 2023 -$ 0.78 (81.40%)$ 13.94$ 15.319.83%
May 10, 2023 -$ 0.21 (-72.73%)$ 12.19$ 12.15-0.33%
Mar 6, 2023 -$ 0.79 (-5.95%)$ 10.63$ 10.781.41%
Nov 7, 2022 -$ 0.80 (5.26%)$ 22.05$ 19.20-12.93%
Aug 11, 2022 -$ 0.74 (2.78%)$ 12.61$ 12.630.16%
May 12, 2022 -$ 0.69 (6.15%)$ 5.66$ 5.944.95%
Mar 15, 2022 -$ 0.89 (-30.47%)$ 8.18$ 9.4916.01%

FAQs

When does Entrada Therapeutics (TRDA) report earnings?

Entrada Therapeutics released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.

What is Entrada Therapeutics (TRDA) stock EPS forecast?

Entrada Therapeutics beat analysts’ expectations during the last earnings period by -6.93%. Entrada Therapeutics reported earnings of -$ 0.94 per share on Nov 5, 2026, while the forecasted EPS was -$ 1.01

Market Closed

TRDA
Entrada Therapeutics
$ 5.09
-1.55%   Last 24H
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Updated 2 days ago